Abeona Therapeutics Inc
F:PCJP
Abeona Therapeutics Inc
F:PCJP
Price:
0.1145
EUR
6.61%
Market Closed
Market Cap:
€28.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
F
|
Fifth Third Bancorp
SWB:FFH
|
US |
|
W
|
Walmart Inc
XETRA:WMT
|
US |
|
C
|
Chargeurs SA
LSE:0E1Y
|
FR |
|
W
|
WEC Energy Group Inc
DUS:WIC
|
US |
|
A
|
Alphabet Inc
LSE:0RIH
|
US |
|
R
|
RedTape
NSE:REDTAPE
|
IN |
Balance Sheet
Balance Sheet Decomposition
Abeona Therapeutics Inc
Abeona Therapeutics Inc
Balance Sheet Decomposition is not available for
Abeona Therapeutics Inc
Abeona Therapeutics Inc
Balance Sheet
Abeona Therapeutics Inc
Abeona Therapeutics Inc
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
2
|
0
|
1
|
0
|
3
|
1
|
7
|
3
|
0
|
0
|
12
|
40
|
69
|
138
|
19
|
129
|
13
|
33
|
14
|
14
|
23
|
78
|
|
| Cash Equivalents |
1
|
1
|
2
|
0
|
1
|
0
|
3
|
1
|
7
|
3
|
0
|
0
|
12
|
40
|
69
|
138
|
19
|
129
|
13
|
33
|
14
|
14
|
23
|
78
|
|
| Short-Term Investments |
8
|
2
|
1
|
0
|
3
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
66
|
0
|
82
|
12
|
38
|
38
|
74
|
113
|
|
| Total Receivables |
1
|
1
|
0
|
5
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
2
|
2
|
7
|
|
| Accounts Receivables |
1
|
1
|
0
|
5
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Other Current Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
3
|
3
|
7
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
12
|
5
|
3
|
5
|
5
|
8
|
3
|
1
|
8
|
3
|
2
|
1
|
12
|
41
|
69
|
141
|
89
|
132
|
98
|
55
|
53
|
56
|
101
|
205
|
|
| PP&E Net |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
21
|
18
|
22
|
11
|
8
|
8
|
14
|
|
| PP&E Gross |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
21
|
18
|
22
|
11
|
8
|
8
|
14
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
7
|
11
|
12
|
13
|
15
|
17
|
|
| Intangible Assets |
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
5
|
7
|
8
|
4
|
43
|
36
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Goodwill |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
33
|
33
|
33
|
33
|
33
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Other Assets |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
33
|
33
|
33
|
33
|
33
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
20
N/A
|
12
-39%
|
11
-6%
|
7
-35%
|
6
-11%
|
9
+42%
|
4
-54%
|
2
-62%
|
9
+450%
|
4
-57%
|
2
-55%
|
1
-65%
|
17
+2 667%
|
80
+383%
|
111
+39%
|
179
+61%
|
174
-2%
|
223
+28%
|
151
-32%
|
80
-47%
|
64
-19%
|
64
0%
|
109
+70%
|
220
+102%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
3
|
2
|
2
|
3
|
1
|
2
|
3
|
4
|
3
|
2
|
2
|
1
|
2
|
1
|
4
|
2
|
6
|
4
|
5
|
4
|
2
|
2
|
3
|
8
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
4
|
7
|
5
|
7
|
6
|
7
|
7
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
8
|
0
|
9
|
0
|
1
|
0
|
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
12
|
|
| Other Current Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
7
|
4
|
7
|
1
|
1
|
5
|
3
|
10
|
28
|
32
|
5
|
0
|
5
|
0
|
0
|
|
| Total Current Liabilities |
5
|
4
|
11
|
4
|
11
|
2
|
8
|
9
|
14
|
12
|
7
|
9
|
3
|
2
|
8
|
6
|
20
|
39
|
42
|
17
|
8
|
13
|
17
|
30
|
|
| Long-Term Debt |
14
|
14
|
6
|
8
|
6
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
13
|
8
|
|
| Other Liabilities |
0
|
0
|
2
|
0
|
0
|
1
|
2
|
14
|
15
|
9
|
12
|
6
|
9
|
11
|
4
|
3
|
20
|
6
|
5
|
12
|
30
|
36
|
35
|
23
|
|
| Total Liabilities |
19
N/A
|
18
-7%
|
18
+1%
|
12
-35%
|
16
+42%
|
9
-48%
|
15
+81%
|
29
+86%
|
30
+3%
|
21
-28%
|
19
-12%
|
15
-18%
|
12
-23%
|
12
+4%
|
12
-2%
|
9
-28%
|
40
+364%
|
45
+11%
|
49
+8%
|
28
-42%
|
38
+33%
|
49
+31%
|
65
+32%
|
60
-7%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
1
|
|
| Retained Earnings |
47
|
54
|
65
|
66
|
78
|
114
|
236
|
242
|
251
|
255
|
268
|
266
|
296
|
311
|
333
|
360
|
410
|
487
|
571
|
656
|
695
|
750
|
813
|
742
|
|
| Additional Paid In Capital |
48
|
49
|
58
|
62
|
68
|
115
|
225
|
215
|
230
|
238
|
251
|
251
|
301
|
378
|
431
|
529
|
544
|
664
|
672
|
706
|
722
|
764
|
857
|
901
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
6
N/A
|
7
-16%
|
4
+37%
|
10
-136%
|
1
N/A
|
11
N/A
|
27
-141%
|
21
+23%
|
18
+15%
|
17
+3%
|
15
+13%
|
5
N/A
|
68
+1 310%
|
99
+46%
|
170
+72%
|
134
-21%
|
178
+33%
|
103
-42%
|
51
-50%
|
27
-48%
|
15
-45%
|
44
+197%
|
159
+262%
|
|
| Total Liabilities & Equity |
20
N/A
|
12
-39%
|
11
-6%
|
7
-35%
|
6
-11%
|
9
+42%
|
4
-54%
|
2
-62%
|
9
+450%
|
4
-57%
|
2
-55%
|
1
-65%
|
17
+2 667%
|
80
+383%
|
111
+39%
|
179
+61%
|
174
-2%
|
223
+28%
|
151
-32%
|
80
-47%
|
64
-19%
|
64
0%
|
109
+70%
|
220
+102%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
4
|
6
|
18
|
27
|
46
|
55
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Other Abeona Therapeutics Inc listings:
Discover More
